We believe there is substantial opportunity to invest in the large molecule ecosystem to help accelerate the development, manufacturing and distribution of lifesaving therapeutics.
The healthcare industry is seeing an increased emphasis on emerging therapeutic modalities such as cell and gene therapy. But the ecosystem required to support these sectors is still young and fragmented.
Working with businesses across this developing sector, we support the growth of cutting-edge companies that are producing and distributing vaccines, therapeutics, antibiotics, diagnostics and more. With extensive experience in biopharma and adjacent areas like pharma services, our investment professionals partner with companies focused on large molecule therapeutics—a growing and vital component of biopharma.